Bandaríkin - enska - NLM (National Library of Medicine)

eyevance pharmaceuticals - fluorometholone acetate (unii: 9i50c3i3ok) (fluorometholone - unii:sv0csg527l) - flarex (fluorometholone acetate ophthalmic suspension) 0.1% is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye. contraindicated in acute superficial herpes simplex keratitis, vaccinia, varicella, and most other viral diseases of cornea and conjunctiva; mycobacterial infection of the eye; fungal diseases; acute purulent untreated infections, which like other diseases caused by microorganisms, may be masked or enhanced by the presence of the steroid; and in those persons who have known hypersensitivity to any component of this preparation.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - fluorometholone acetate -

Ástralía - enska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

de sangosse sa - metaldehyde - pellet (eg snail bait) - metaldehyde aldehyde active 50.0 g/kg - molluscicide - agricultural areas - see label | cereal crop | commercial/industrial land | fruit - refer to label | oilseed crops - see label | - slug | small brown snail | snail - see label for exceptions | snail and slug - except brown snails

Malta - enska - Medicines Authority

s.a alcon-couvreur n.v. - fluorometholone acetate 1 mg/ml - eye drops, suspension

Bandaríkin - enska - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - chlordiazepoxide hydrochloride (unii: mfm6k1xwdk) (chlordiazepoxide - unii:6rz6xez3cr) - chlordiazepoxide hydrochloride 25 mg - chlordiazepoxide hcl capsules are indicated for the management of anxiety disorders or for the short term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. the effectiveness of chlordiazepoxide hcl capsules in long term use, that is, more than 4 months, has not been assessed by systematic clinical studies. the physician should periodically reassess the usefulness of the drug for the individual patient. chlordiazepoxide hcl capsules are contraindicated in patients with known hypersensitivity to the drug. chlordiazepoxide hydrochloride capsules are classified by the drug enforcement administration as a schedule iv controlled substance. withdrawal symptoms, similar in character to those noted with barbiturates and alcohol (convulsions, tremor, abdominal and muscle cramps, vomiting and sweating), have occurred following abrupt discon

Bandaríkin - enska - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - eszopiclone (unii: uzx80k71oe) (eszopiclone - unii:uzx80k71oe) - eszopiclone 2 mg - eszopiclone tablets are indicated for the treatment of insomnia. in controlled outpatient and sleep laboratory studies, eszopiclone administered at bedtime decreased sleep latency and improved sleep maintenance.   the clinical trials performed in support of efficacy were up to 6 months in duration. the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6-week study (adults only), at the end of both 2-week studies (elderly only) and at the end of the 6-month study (adults only). eszopiclone tablets are contraindicated in patients with known hypersensitivity to eszopiclone. hypersensitivity reactions include anaphylaxis and angioedema [see warnings and precautions (5.3) ]. pregnancy category c there are no adequate and well-controlled studies in pregnant women. eszopiclone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.   oral administration of eszopiclone to pregnant rats (62.5, 125, or 250 mg/kg/day) and rabbits (

Bandaríkin - enska - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - postherpetic neuralgia gabapentin capsules is indicated for the management of postherpetic neuralgia in adults. epilepsy gabapentin capsules, usp is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. gabapentin capsules, usp is also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 to 12 years. gabapentin capsules is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. the abuse and dependence potential of gabapentin capsules has not been evaluated in human studies.

Bandaríkin - enska - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - indomethacin (unii: xxe1cet956) (indomethacin - unii:xxe1cet956) - indomethacin capsules are indicated for: - moderate to severe rheumatoid arthritis including acute flares of chronic disease. - moderate to severe ankylosing spondylitis. - moderate to severe osteoarthritis. - acute painful shoulder (bursitis and/or tendinitis). - acute gouty arthritis. indomethacin capsules are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to indomethacin or any components of the drug product [see warnings and precautions (5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8) ] - in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1) ] use of nsaids, including indomethacin capsules, during the third trimester of pregnancy increases the risk of premature closure of the fetal duct

Kanada - enska - Health Canada

novartis pharmaceuticals canada inc - fluorometholone acetate - suspension - 0.1% - fluorometholone acetate 0.1% - corticosteroids

Kanada - enska - Health Canada

glaxosmithkline inc - respiratory syncytial virus prefusion f protein (rsvpref3) - powder for suspension - 120mcg - respiratory syncytial virus prefusion f protein (rsvpref3) 120mcg